- Home
- CVKD vs SCNX Comparison
CVKD vs SCNX Comparison
Compare CVKD & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- SCNX
- Stock Information
- Founded
- CVKD 2022
- SCNX 2010
- Country
- CVKD United States
- SCNX United States
- Employees
- CVKD N/A
- SCNX N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- SCNX Other Pharmaceuticals
- Sector
- CVKD Health Care
- SCNX Health Care
- Exchange
- CVKD Nasdaq
- SCNX Nasdaq
- Market Cap
- CVKD 27.0M
- SCNX 31.5M
- IPO Year
- CVKD 2023
- SCNX 2020
- Fundamental
- Price
- CVKD $11.25
- SCNX $0.63
- Analyst Decision
- CVKD Strong Buy
- SCNX
- Analyst Count
- CVKD 1
- SCNX 0
- Target Price
- CVKD $32.00
- SCNX N/A
- AVG Volume (30 Days)
- CVKD 21.9K
- SCNX 59.7M
- Earning Date
- CVKD 11-10-2025
- SCNX 11-13-2025
- Dividend Yield
- CVKD N/A
- SCNX N/A
- EPS Growth
- CVKD N/A
- SCNX N/A
- EPS
- CVKD N/A
- SCNX N/A
- Revenue
- CVKD N/A
- SCNX $653,391.00
- Revenue This Year
- CVKD N/A
- SCNX N/A
- Revenue Next Year
- CVKD N/A
- SCNX N/A
- P/E Ratio
- CVKD N/A
- SCNX N/A
- Revenue Growth
- CVKD N/A
- SCNX 207.88
- 52 Week Low
- CVKD $8.74
- SCNX $0.46
- 52 Week High
- CVKD $22.90
- SCNX $8.72
- Technical
- Relative Strength Index (RSI)
- CVKD 39.39
- SCNX 44.24
- Support Level
- CVKD $11.51
- SCNX $0.65
- Resistance Level
- CVKD $13.01
- SCNX $0.78
- Average True Range (ATR)
- CVKD 0.82
- SCNX 0.14
- MACD
- CVKD -0.14
- SCNX -0.02
- Stochastic Oscillator
- CVKD 21.29
- SCNX 1.95
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.